MMP‐13 degrades ECM components, including Ln‐5, continuously promoting endothelial cell migration in the ECM, the release of VEGF and bFGF, and ultimately the generation of endothelium‐dependent vascular tumours. This evidence concerns the gene MMP13 and vascular neoplasm.